CEP164 p.Pro495Arg
c.1484C>G · rs59763167 · VCV235424
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0778 | likely benign |
|---|---|---|
| REVEL | 0.151 | moderately benign-leaning |
| SaProt | LLR -6.48 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -4.6 | GERP -2.8 |
| Regional constraint | o/e 0.97 | unconstrained · MANE · 74 kb · p 0.19 · regional, not allelic |
| Overall | ||
| CADD | 0.17 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 4.28% | 23 |
| East Asian | 1.75% | 57 |
| Remaining individualsnot grpmax-eligible | 0.51% | 196 |
| Middle Eastern | 0.117% | 852 |
| African / African-American | 0.0469% | 2,134 |
| European (non-Finnish) | 0.0133% | 7,510 |
| Admixed American | 0.0103% | 9,687 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00343% | 29,150 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CEP164
- Protein
- p.Pro495Arg
- Coding
- c.1484C>G
- MANE Select
- NM_014956
- dbSNP
- rs59763167
- Type
- single nucleotide variant
- Location
- chr11:117381775 (GRCh38)
- Gene constraint
- LOEUF 1.009 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 63.08 · 4 PDB
- Residue 495
- the 'disordered' region
Disease context
nephronophthisis 15 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Senior-Loken syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- CEP164 p.Pro495Thr Uncertain significance ★ ⚠ same residue
- CEP164 p.Pro495fs Pathogenic/Likely pathogenic ★★ same residue
- CEP164 c.1234-2A>T Likely pathogenic ★★ same condition
- CEP164 c.1724+1G>A Likely pathogenic ★★ same condition
- CEP164 c.1934+1G>A Likely pathogenic ★★ same condition
- CEP164 c.2361+1G>A Likely pathogenic ★★ same condition
- CEP164 c.2493+1G>A Likely pathogenic ★★ same condition
- CEP164 c.2914-1G>C Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep164-p-pro495arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown